ROKIT Healthcare Inc. (KOSDAQ:376900)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,020
-4,380 (-19.55%)
At close: Oct 22, 2026

ROKIT Healthcare Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32,81426,24713,11112,4189,1516,741
Revenue Growth
106.19%100.19%5.59%35.70%35.76%68.94%
Gross Profit
15,92615,6705,9644,0263,0641,615
Operating Income
-15,39335.58-6,042-7,568-13,873-17,320
Net Income
-12,690-2,845-7,64616,6001,875-56,247
Earnings Per Share
-812.68-222.00-978.30-829.59-1232.84-8218.00
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
South Korea
23,52814,6787,3609,9736,8045,023
Overseas
9,28611,5695,7512,4452,3471,718
Total
32,81426,24713,11112,4189,1516,741

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
63,15832,0794,6012,4894,8774,750
Total Debt
25,52226,15214,72911,4329,1298,840
Net Cash (Debt)
37,6365,927-10,128-8,943-4,252-4,090
Net Cash Growth
461.12%-----
Net Cash Per Share
2409.60461.84-1295.97-753.00-360.30-597.54

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25,755-17,230-5,002-3,916-6,586-11,823
Capital Expenditures
-427.41-163.34-20.45-148.65-191.13-297.44
Free Cash Flow
-26,183-17,393-5,023-4,065-6,777-12,121
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
48.54%59.70%45.49%32.42%33.49%23.96%
Operating Margin
-46.91%0.14%-46.09%-60.94%-151.61%-256.95%
Pretax Margin
-35.98%-7.31%-55.96%135.54%22.15%-834.99%
Profit Margin
-38.67%-10.84%-58.31%133.68%20.48%-834.44%
FCF Margin
-79.79%-66.27%-38.31%-32.73%-74.06%-179.81%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-132.39----
PS Ratio
9.5438.97----